4.7 Review

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis

期刊

BIOMEDICINES
卷 9, 期 4, 页码 -

出版社

MDPI
DOI: 10.3390/biomedicines9040442

关键词

idiopathic pulmonary fibrosis; microbiome; virome

向作者/读者索取更多资源

The interest in the lung microbiome and virome and their contribution to the pathogenesis of idiopathic pulmonary fibrosis (IPF) has been increasing. Higher microbial burden is associated with worse prognosis but no specific microbe has been identified to contribute to this. Infection is considered a cause of acute exacerbation of IPF, but the association of viral infection with AE-IPF has not been established.
The interest in the lung microbiome and virome and their contribution to the pathogenesis, perpetuation and progression of idiopathic pulmonary fibrosis (IPF) has been increasing during the last decade. The utilization of high-throughput sequencing to detect microbial and/or viral genetic material in bronchoalveolar lavage fluid or lung tissue samples has amplified the ability to identify and quantify specific microbial and viral populations. In stable IPF, higher microbial burden is associated with worse prognosis but no specific microbe has been identified to contribute to this. Additionally, no causative relation has been established. Regarding viral infections, although in the past they have been associated with IPF, causation has not been proved. Although in the past the diagnosis of acute exacerbation of IPF (AE-IPF) was not considered in patients with overt infection, this was amended in the last few years and infection is considered a cause for exacerbation. Besides this, a higher microbial burden has been found in the lungs of patients with AE-IPF and an association with higher morbidity and mortality has been confirmed. In contrast, an association of AE-IPF with viral infection has not been established. Despite the progress during the last decade, a comprehensive knowledge of the microbiome and virome in IPF and their role in disease pathogenesis are yet elusive. Although association with disease severity, risk for progression and mortality has been established, causation has not been proven and the potential use as a biomarker or the benefits of antimicrobial therapeutic strategies are yet to be determined.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据